Bottom line
How much do PBE and IBBQ overlap?
55% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 66.8% of PBE's assets and 61.8% of IBBQ's. They share a meaningful core but differ in the rest of the portfolio.
IBBQ holds far more positions (261 vs 33), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PBE and IBBQ have in common
| Holding | % of PBE | % of IBBQ | Overlap |
|---|---|---|---|
| Invesco Private Prime Fund | 12.89% | 14.20% | 12.89% |
| Regeneron Pharmaceuticals, Inc. | 5.47% | 5.08% | 5.08% |
| Amgen Inc. | 5.22% | 7.10% | 5.22% |
| Vertex Pharmaceuticals Inc. | 4.99% | 7.38% | 4.99% |
| Invesco Private Government Fund | 4.97% | 5.48% | 4.97% |
| Royalty Pharma PLC | 4.94% | 1.90% | 1.90% |
| Biogen Inc. | 4.79% | 2.29% | 2.29% |
| Gilead Sciences, Inc. | 4.43% | 7.39% | 4.43% |
| United Therapeutics Corp. | 4.08% | 1.94% | 1.94% |
| Illumina, Inc. | 3.51% | 1.98% | 1.98% |
| Alnylam Pharmaceuticals, Inc. | 3.17% | 3.19% | 3.17% |
| Incyte Corp. | 3.06% | 1.53% | 1.53% |
| Neurocrine Biosciences, Inc. | 2.66% | 1.26% | 1.26% |
| Exelixis, Inc. | 2.64% | 1.04% | 1.04% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PBE
- CareDx, Inc. — 5.04%
- Bio-Techne Corp. — 3.73%
- Protagonist Therapeutics, Inc. — 3.40%
- Vericel Corp. — 3.27%
- Repligen Corp. — 3.04%
- Acadia Pharmaceuticals Inc. — 3.02%
- Halozyme Therapeutics, Inc. — 2.98%
- Qiagen N.V. — 2.89%
- BioMarin Pharmaceutical Inc. — 2.82%
- BioCryst Pharmaceuticals, Inc. — 2.63%
- Veracyte, Inc. — 2.60%
Only in IBBQ
- Revolution Medicines, Inc. — 2.48%
- argenx SE — 1.89%
- Insmed Inc. — 1.83%
- Roivant Sciences Ltd. — 1.71%
- Viatris Inc. — 1.49%
- Moderna, Inc. — 1.48%
- Guardant Health, Inc. — 1.35%
- Jazz Pharmaceuticals PLC — 1.16%
- Ascendis Pharma A/S — 1.10%
- Summit Therapeutics Inc. — 1.08%
- BridgeBio Pharma, Inc. — 1.02%
Asset mix
| Asset type | PBE | IBBQ |
|---|---|---|
| Stocks | 100.1% | 99.9% |
| Cash & short-term funds | 17.9% | 19.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | PBE | IBBQ |
|---|---|---|
| US | 108.6% | 103.8% |
| GB | 4.9% | 2.7% |
| NL | 2.9% | 2.5% |
| IE | — | 1.9% |
| BM | — | 1.7% |
| KY | 1.6% | 0.6% |
| FR | — | 1.5% |
| DK | — | 1.2% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PBE and IBBQ overlap?
What stocks do PBE and IBBQ have in common?
Should I own both PBE and IBBQ?
Which holds more stocks, PBE or IBBQ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.